Legislation on Counterfeit Medicines in the region

Lorem Ipsum Dolor

Information

Type

Cuestionario

Version

File Size

4.00 KB

Published Date

01/01/2017

Period

Previous

Categoría

ASIPI Writes,Previous Periods

Authors

ASIPI

Attached Files:

Array ( [icon] => [view_count] => 12 [download_count] => 3 [link_label] => Download [version] => [quota] => [access] => Array ( [0] => guest ) [package_size] => 4.00 KB [publish_date] => [expire_date] => [avail_date_ts] => [avail_date] => [expire_date_ts] => [download_limit_per_user] => [ID] => 324 [post_author] => 3154 [post_date] => 2017-02-22 11:10:09 [post_date_gmt] => 2017-02-22 17:10:09 [post_content] =>

REGULATION AGAINST THE COUNTERFEITING OF PHARMACEUTICAL PRODUCTS IN LATIN AMERICA

  1. REGULATORY FRAMEWORK
  2. AUTHORITIES
  3. PASSABLE SUBJECTS OF PENALTY
  4. TYPE OF SANCTIONS
  5. FALSIFIED GOODS DESTINATION SEIZED AT THE END OF THE PROCESS
  6. PRECAUTIONARY MEASURES (MC)
  7. MEASURES IN BORDER
[post_title] => Legislation on Counterfeit Medicines in the region [post_excerpt] => REGULATION AGAINST THE COUNTERFEITING OF PHARMACEUTICAL PRODUCTS IN LATIN AMERICA REGULATORY FRAMEWORK AUTHORITIES PASSABLE SUBJECTS OF PENALTY TYPE OF SANCTIONS FALSIFIED GOODS DESTINATION SEIZED AT THE END OF THE PROCESS PRECAUTIONARY MEASURES (MC) MEASURES IN BORDER [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => legislacion-en-la-falsificacion-de-medicamentos-en-la-region [to_ping] => [pinged] => [post_modified] => 2022-05-31 02:16:27 [post_modified_gmt] => 2022-05-31 02:16:27 [post_content_filtered] => [post_parent] => 0 [guid] => http://asipi.org/?post_type=publicacion&p=2608 [menu_order] => 0 [post_type] => wpdmpro [post_mime_type] => [comment_count] => 0 [filter] => raw [post_content_ml] => [:es]

REGULACIÓN CONTRA LA FALSIFICACIÓN DE PRODUCTOS FARMACÉUTICOS EN AMÉRICA LATINA

  1.  MARCO REGULATORIO
  2.  AUTORIDADES
  3.  SUJETOS PASIBLES DE SANCIÓN
  4.  TIPO DE SANCIONES
  5.  DESTINO DE MERCADERÍA FALSIFICADA INCAUTADA AL FINAL DEL PROCESO
  6.  MEDIDAS CAUTELARES (MC)
  7.  MEDIDAS EN FRONTERA
[:en]

REGULATION AGAINST THE COUNTERFEITING OF PHARMACEUTICAL PRODUCTS IN LATIN AMERICA

  1. REGULATORY FRAMEWORK
  2. AUTHORITIES
  3. PASSABLE SUBJECTS OF PENALTY
  4. TYPE OF SANCTIONS
  5. FALSIFIED GOODS DESTINATION SEIZED AT THE END OF THE PROCESS
  6. PRECAUTIONARY MEASURES (MC)
  7. MEASURES IN BORDER
[:pb]

Legislation on Counterfeit Medicines in the region

[:] [post_content_langs] => Array ( [es] => 1 [en] => 1 [pb] => 1 ) [post_title_ml] => [:es]Legislación en la falsificación de medicamentos en la región[:en]Legislation on Counterfeit Medicines in the region[:] [post_title_langs] => Array ( [es] => 1 [en] => 1 ) [title] => Legislation on Counterfeit Medicines in the region [description] =>

REGULATION AGAINST THE COUNTERFEITING OF PHARMACEUTICAL PRODUCTS IN LATIN AMERICA

  1. REGULATORY FRAMEWORK
  2. AUTHORITIES
  3. PASSABLE SUBJECTS OF PENALTY
  4. TYPE OF SANCTIONS
  5. FALSIFIED GOODS DESTINATION SEIZED AT THE END OF THE PROCESS
  6. PRECAUTIONARY MEASURES (MC)
  7. MEASURES IN BORDER
[excerpt] => [thumb] => [preview] => https://staging.asipi.org/biblioteca/wp-content/uploads/sites/14/2019/02/cover-AsipiEscribe.jpg [preview_alt] => [preview_title] => cover-AsipiEscribe [featured_image] => [author_name] => editor ASIPI [author_profile_url] => https://staging.asipi.org/biblioteca/en/author/editorasipi/ [avatar_url] => https://asipi.org/biblioteca/wp-content/uploads/sites/14/2019/11/AF-Asipi-Logo-SinLeyenda.jpg [avatar] => [create_date] => Wednesday February 22nd, 2017 [update_date] => 31 May, 2022 [files] => Array ( [1542994242308] => MASTER_FINAL.pdf [1542994130363] => Addendum-Anexo-No-1-Argentina.pdf [1542994117578] => Addendum-Anexo-No-2-Belize.pdf [1542994111750] => Addendum-Anexo-No-3-Bolivia.pdf [1542994109325] => Addendum-Anexo-No-4-Costa-Rica.pdf [1542994108059] => Addendum-Anexo-No-5-Brazil.pdf [1542994092703] => Addendum-Anexo-No-6-Chile.pdf [1542994070064] => Addendum-Anexo-No-7-Colombia.pdf [1542994036997] => Addendum-Anexo-No-8-Ecuador.pdf [1542994035258] => Addendum-Anexo-No-09-El-Salvador.pdf [1542994033493] => Addendum-Anexo-No-10-Guatemala.pdf [1542994007498] => Addendum-Anexo-No-11-Honduras.pdf [1542994006251] => Addendum-Anexo-No-12-Mexico.pdf [1542993988559] => Addendum-Anexo-No-13-Nicaragua.pdf [1542993977192] => Addendum-Anexo-No-14-Panama.pdf [1542993967827] => Addendum-Anexo-No-15-Paraguay.pdf [1542993929158] => Addendum-Anexo-No-16-Peru.pdf [1542993912779] => Addendum-Anexo-No-17-Republica-Dominicana.pdf [1542993883610] => Addendum-Anexo-No-18-Uruguay.pdf [1542993881242] => Addendum-Anexo-No-19-Venezuela.pdf ) [file_count] => 20 [file_list] =>
File
MASTER_FINAL.pdf
Addendum-Anexo-No-1-Argentina.pdf
Addendum-Anexo-No-2-Belize.pdf
Addendum-Anexo-No-3-Bolivia.pdf
Addendum-Anexo-No-4-Costa-Rica.pdf
Addendum-Anexo-No-5-Brazil.pdf
Addendum-Anexo-No-6-Chile.pdf
Addendum-Anexo-No-7-Colombia.pdf
Addendum-Anexo-No-8-Ecuador.pdf
Addendum-Anexo-No-09-El-Salvador.pdf
Addendum-Anexo-No-10-Guatemala.pdf
Addendum-Anexo-No-11-Honduras.pdf
Addendum-Anexo-No-12-Mexico.pdf
Addendum-Anexo-No-13-Nicaragua.pdf
Addendum-Anexo-No-14-Panama.pdf
Addendum-Anexo-No-15-Paraguay.pdf
Addendum-Anexo-No-16-Peru.pdf
Addendum-Anexo-No-17-Republica-Dominicana.pdf
Addendum-Anexo-No-18-Uruguay.pdf
Addendum-Anexo-No-19-Venezuela.pdf
[play_list] =>
File
MASTER_FINAL.pdf
Addendum-Anexo-No-1-Argentina.pdf
Addendum-Anexo-No-2-Belize.pdf
Addendum-Anexo-No-3-Bolivia.pdf
Addendum-Anexo-No-4-Costa-Rica.pdf
Addendum-Anexo-No-5-Brazil.pdf
Addendum-Anexo-No-6-Chile.pdf
Addendum-Anexo-No-7-Colombia.pdf
Addendum-Anexo-No-8-Ecuador.pdf
Addendum-Anexo-No-09-El-Salvador.pdf
Addendum-Anexo-No-10-Guatemala.pdf
Addendum-Anexo-No-11-Honduras.pdf
Addendum-Anexo-No-12-Mexico.pdf
Addendum-Anexo-No-13-Nicaragua.pdf
Addendum-Anexo-No-14-Panama.pdf
Addendum-Anexo-No-15-Paraguay.pdf
Addendum-Anexo-No-16-Peru.pdf
Addendum-Anexo-No-17-Republica-Dominicana.pdf
Addendum-Anexo-No-18-Uruguay.pdf
Addendum-Anexo-No-19-Venezuela.pdf
[audio_player] =>
File
MASTER_FINAL.pdf
Addendum-Anexo-No-1-Argentina.pdf
Addendum-Anexo-No-2-Belize.pdf
Addendum-Anexo-No-3-Bolivia.pdf
Addendum-Anexo-No-4-Costa-Rica.pdf
Addendum-Anexo-No-5-Brazil.pdf
Addendum-Anexo-No-6-Chile.pdf
Addendum-Anexo-No-7-Colombia.pdf
Addendum-Anexo-No-8-Ecuador.pdf
Addendum-Anexo-No-09-El-Salvador.pdf
Addendum-Anexo-No-10-Guatemala.pdf
Addendum-Anexo-No-11-Honduras.pdf
Addendum-Anexo-No-12-Mexico.pdf
Addendum-Anexo-No-13-Nicaragua.pdf
Addendum-Anexo-No-14-Panama.pdf
Addendum-Anexo-No-15-Paraguay.pdf
Addendum-Anexo-No-16-Peru.pdf
Addendum-Anexo-No-17-Republica-Dominicana.pdf
Addendum-Anexo-No-18-Uruguay.pdf
Addendum-Anexo-No-19-Venezuela.pdf
[page_url] => https://staging.asipi.org/biblioteca/en/download/legislacion-en-la-falsificacion-de-medicamentos-en-la-region/ [page_link] => Legislation on Counterfeit Medicines in the region [page_url_qr] => Legislation on Counterfeit Medicines in the region [btnclass] => btn btn-primary [tags] => [file_size] => 4.00 KB [download_url] => https://staging.asipi.org/biblioteca/en/download/legislacion-en-la-falsificacion-de-medicamentos-en-la-region/?wpdmdl=324&refresh=6a2746d0505b01780958928 [download_link] => Download [download_link_extended] => Download [download_link_popup] => Download [formatted] => 1 [__template] => [__template_type] => page [popover_preview] =>
Legislation on Counterfeit Medicines in the region

Legislation on Counterfeit Medicines in the region

Updated on 31 May, 2022
4.00 KB
3 downloads
Legislation on Counterfeit Medicines in the region
[wpcf-tipo] => Cuestionario ) Array ( [0] => [1] => [2] => [3] => [4] => [5] => [6] => [7] => [8] => [9] => [10] => [11] => [12] => [13] => [14] => [15] => [16] => [17] => [18] => [19] => ) -----------------

MASTER_FINAL.pdf

Addendum-Anexo-No-1-Argentina.pdf

Addendum-Anexo-No-2-Belize.pdf

Addendum-Anexo-No-3-Bolivia.pdf

Addendum-Anexo-No-4-Costa-Rica.pdf

Addendum-Anexo-No-5-Brazil.pdf

Addendum-Anexo-No-6-Chile.pdf

Addendum-Anexo-No-7-Colombia.pdf

Addendum-Anexo-No-8-Ecuador.pdf

Addendum-Anexo-No-09-El-Salvador.pdf

Addendum-Anexo-No-10-Guatemala.pdf

Addendum-Anexo-No-11-Honduras.pdf

Addendum-Anexo-No-12-Mexico.pdf

Addendum-Anexo-No-13-Nicaragua.pdf

Addendum-Anexo-No-14-Panama.pdf

Addendum-Anexo-No-15-Paraguay.pdf

Addendum-Anexo-No-16-Peru.pdf

Addendum-Anexo-No-17-Republica-Dominicana.pdf

Addendum-Anexo-No-18-Uruguay.pdf

Addendum-Anexo-No-19-Venezuela.pdf


okkk

REGULATION AGAINST THE COUNTERFEITING OF PHARMACEUTICAL PRODUCTS IN LATIN AMERICA

  1. REGULATORY FRAMEWORK
  2. AUTHORITIES
  3. PASSABLE SUBJECTS OF PENALTY
  4. TYPE OF SANCTIONS
  5. FALSIFIED GOODS DESTINATION SEIZED AT THE END OF THE PROCESS
  6. PRECAUTIONARY MEASURES (MC)
  7. MEASURES IN BORDER

Share: